Constantijn J. Halkes
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Long-term outcome of a DLI-based treatment strategy in patients with relapsed AML after TCD allogeneic stem cell transplantation is hampered by GvHD and late relapse.
Journal: Transplantation and cellular therapy
Published: June 02, 2026
Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag.
Journal: NEJM evidence
Published: April 28, 2026
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study.
Journal: American journal of hematology
Published: February 05, 2026
Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry.
Journal: Annals of hematology
Published: December 05, 2025
Selective lymphodepletion underlies the efficacy of horse anti-thymocyte globulin-based immunosuppressive therapy in aplastic anemia.
Journal: Haematologica
Published: October 03, 2025
Correction: Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.
Journal: Frontiers in immunology
Published: May 28, 2025
An extraction pipeline for analysis of hematopoietic stem cell transplantation data.
Journal: Bone marrow transplantation
Published: May 28, 2025
Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working party.
Journal: Bone marrow transplantation
Published: March 05, 2025
Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT.
Journal: Bone marrow transplantation
Published: February 07, 2025
Filgrastim after autologous stem cell transplantation shortens time to neutrophil recovery and hospital stay.
Journal: Annals of hematology
Published: January 15, 2025
DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2024
Last Updated: 09/26/2026